Specialized Disclosure Report (sd)
May 23 2019 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
ALLERGAN PLC
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Ireland
|
|
001-36867
|
|
98-1114402
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
Clonshaugh Business and Technology Park
Coolock, Dublin, Ireland
|
|
D17 E400
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
A. Robert D. Bailey
EVP and Chief Legal Officer and Corporate Secretary (862)
261-7000
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in
this form applies:
☒
|
Rule
13p-1
under the Securities Exchange Act (17 CFR
240.13p-1)
for the reporting period from January 1 to December 31, 2018.
|
Section 1Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
This Form SD
of Allergan plc (the Company) is filed pursuant to Rule
13p-1
promulgated under the Securities Exchange Act of 1934 for the reporting period January 1, 2018 to December 31, 2018.
A copy of the Companys Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD and is publicly available on Allergans
website at
https://www.allergan.com/investors/financial-information/sec-filings
.
Item 1.02 Exhibit
As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01
to this report.
Section 2Exhibits
Item 2.01 Exhibits
The following
exhibit is filed as part of this report.
|
|
|
Exhibit No.
|
|
Description
|
1.01
|
|
Conflict Minerals Report of Allergan plc
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly
authorized undersigned.
|
|
|
|
|
Allergan plc
|
By: /s/ A. Robert D. Bailey
|
A. Robert D. Bailey
|
|
|
|
May 23, 2019
|
EVP and Chief Legal Officer and Corporate Secretary
|
|
|
|
|
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024